![Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study]()
Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized StudyFaivre, S.; Niccoli, P.; Castellano, D.; Valle, J. W.; Hammel, P.; Raoul, J.-L.; Vinik, A.; Van Cutsem, E.; Bang, Y.-J.; Lee, S.-H.; Borbath, I.; Lombard-Bohas, C.; Metrakos, P.; Smith, D.; Chen, J.-S.; Ruszniewski, P.; Seitz, J.-F.; Patyna, S.; Lu, D. R.; Ishak, K. J.; Raymond, E. · Annals of Oncology · 2016